- Home
- INM vs SXTP Comparison
INM vs SXTP Comparison
Compare INM & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- SXTP
- Stock Information
- Founded
- INM 1981
- SXTP 2010
- Country
- INM Canada
- SXTP United States
- Employees
- INM N/A
- SXTP N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- SXTP Health Care
- Exchange
- INM Nasdaq
- SXTP Nasdaq
- Market Cap
- INM 2.3M
- SXTP 2.4M
- IPO Year
- INM N/A
- SXTP 2023
- Fundamental
- Price
- INM $3.12
- SXTP $0.45
- Analyst Decision
- INM
- SXTP Hold
- Analyst Count
- INM 0
- SXTP 1
- Target Price
- INM N/A
- SXTP N/A
- AVG Volume (30 Days)
- INM 84.1K
- SXTP 5.8M
- Earning Date
- INM 02-12-2025
- SXTP 03-31-2025
- Dividend Yield
- INM N/A
- SXTP N/A
- EPS Growth
- INM N/A
- SXTP N/A
- EPS
- INM N/A
- SXTP N/A
- Revenue
- INM $4,832,013.00
- SXTP $462,612.00
- Revenue This Year
- INM N/A
- SXTP $141.35
- Revenue Next Year
- INM N/A
- SXTP $175.16
- P/E Ratio
- INM N/A
- SXTP N/A
- Revenue Growth
- INM N/A
- SXTP 128.99
- 52 Week Low
- INM $2.42
- SXTP $0.41
- 52 Week High
- INM $15.70
- SXTP $7.20
- Technical
- Relative Strength Index (RSI)
- INM 37.82
- SXTP 33.01
- Support Level
- INM $3.03
- SXTP $0.47
- Resistance Level
- INM $3.48
- SXTP $0.67
- Average True Range (ATR)
- INM 0.20
- SXTP 0.10
- MACD
- INM 0.05
- SXTP 0.00
- Stochastic Oscillator
- INM 35.59
- SXTP 12.96
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.